Clinical Case of the Combined Course of Diffuse Toxic Goiter and Autoimmune Ophthalmopathy
Journal Title: Міжнародний ендокринологічний журнал - Year 2014, Vol 2, Issue 58
Abstract
The article presents the experience of treating a patient with diffuse toxic goiter in conjunction with autoimmune ophthalmopathy, about what the patient took thyrostatic drugs, β-blockers, systemic glucocorticoids. On the background of glucocorticoids withdrawal there has been detected an acute exacerbation of the symptoms of ophthalmopathy, which acquired malignant course. Due to the high activity of ophthalmopathy, the lack of effect of pulse therapy with systemic glucocorticoids, patient underwent surgery — transpalpebral orbital decompression.
Authors and Affiliations
Ye. N. Martsinik, T. V. Chursinova, V. N. Serdyuk, L. N. Pastarus, T. L. Krainyak
Keywords
Related Articles
- EP ID EP226842
- DOI -
- Views 64
- Downloads 0
The Endothelium Dysfunction as a Possible Promoter of Development of Non-Functional Pituitary Adenoma
Recently the term of endothelial dysfunction has obtained a wide circulation in clinical neuroendocrinology. The phenomenon plays a significant role in genesis of many cerebrovascular brain pathological conditions. In mo...
Study of Pregnancy Course and Outcomes with Analysis of Possible Risk Factors in Patients with Diabetes Mellitus Type 1
There were examined 53 pregnant patients with type 1 diabetes mellitus. When studying the course of pregnancy and its outcomes with analysis of possible risk factors it was established that they are not rare and first of...
Brief Essay of Medicinal Substances Development, Particularly in Endocrinology
No abstract
Application of antioxidant preparation Hepaval in rational therapy of diabetes mellitus
Lecture presents the data on the current state of diabetes mellitus problem and the role of oxidative stress. In diabetes mellitus, there are ideal conditions for the development of oxidative stress, the main role in whi...
Clinical experience of using herbal medicinal product Glucemedin in the comprehensive treatment of patients with type 2 diabetes mellitus
Background. The current task of treating patients with type 2 diabetes mellitus and dyslipoproteinemia is the analysis of efficiency of the combination of standard hypoglycemic agents with phytotherapeutic drugs, but inf...